发现双重功能阿克里顿作为一种新的抗疟疾化学型
Jane X Kelly1, Martin J Smilkstein, Reto Brun
1Portland Veterans Affairs Medical Centre, Portland, Oregon 97239, USA. kellyja@ohsu.edu
Nature
|April 10, 2009
概括
一种新型的阿克里化合物T3.5显示出对抗多药耐药疟疾的前景. 它针对海姆并增强现有的抗疟疾药物,为持续治疗疟疾提供了一种新的策略.
科学领域:
- 药用化学 医学化学
- 寄生虫学的寄生虫学
- 药物开发 药物开发
背景情况:
- 耐药性是疟疾治疗的一个主要挑战.
- 单疗法和可变药物标加速耐药性.
- 血排毒是寄生虫生存的关键途径,也是脆弱的药物标.
研究的目的:
- 开发一种新的抗疟疾化学型,向血并抵消耐药性.
- 评估化合物T3.5.5的疗效和协同性能.
主要方法:
- 对抗Plasmodium falciparum的acridone化学型T3.5的合成和体外测试.
- 在口服后对T3.5的体内疗效和安全性研究.
- 评估与现有的抗疟疾药物 (洛昆,阿莫迪亚昆,,皮佩拉昆) 的协同效应.
主要成果:
- T3.5对药物敏感性和多药物耐药性Plasmodium falciparum表现出高强度.
- 该化合物表现出"类似于维拉帕米尔"的化学敏感性对洛昆和阿莫迪亚昆.
- 在体外和体内,T3.5与因和皮佩拉因表现出明显的协同作用.
结论:
- 新型阿克里T3.5结合了固有的抗疟疾功效与抵抗功能.
- 这种双重作用分子代表了增强和维持抗疟疾药物组合的新策略.
- T3.5提供了一种有希望的方法来克服疟疾中现有的耐药性.
相关概念视频
Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Aryldiazonium Salts to Azo Dyes: Diazo Coupling
The reaction of weakly electrophilic aryldiazonium (also called arenediazonium) salts with highly activated aromatic compounds leads to the formation of products with an —N=N— link, called an azo linkage. This reaction, presented in Figure 1, is known as diazo coupling and occurs without the loss of the nitrogen atoms of the aryldiazonium salt. Highly activated aromatic compounds such as phenols or arylamines favor the diazo coupling reaction. The coupling generally occurs at the para position.
Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic antagonists are called...
Principles of Drug Action
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...

